Senaste uppdateringen :
28/04/2024
InfoStab
Infostab
Förteckning över substanser
Förteckning över substanser
Sammanfattande listor
Sammanfattande listor
Sök efter kompatibilitet
Sök efter kompatibilitet
Kompatibilitetstabell
Kompatibilitetstabell
Hänvisningar
Hänvisningar
Forskargrupper
Forskargrupper
Valistab
Valistab
Posters
Posters
Anslutningar
Anslutningar
Sponsorer
Sponsorer
Författare
Författare
Användaranvisning
Användaranvisning
Nyhetsbladet
Nyhetsbladet
Forskargrupper - University of Rochester Medical Center, Department of Pharmacy   Pdf  
Förenta Staterna
Sjukhus
University of Rochester Medical Center, Department of Pharmacy
Rochester
Hänvisningar   Hänvisningar   (13)  
1
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspensions.
Atkins J.R, Lull M.E, Decker A.S, Hutchinson D.J. (dhutchinson@sjfc.edu)
Int J Pharm Compound - 2018 - ;22,4:326-328
2
In vitro evaluation of eslicarbazepine delivery via enteral feeding tubes.
Reindel K, Zhao F, Hughes S, Dave V. (vdave@sjfc.edu)
Hosp Pharm - 2017 - ;52,11:752-760
3
Stability of codeine phosphate in an extemporaneously compounded syrup
Dentinger PJ, Swenson CF. ()
Am J Health-Syst Pharm - 2007 - Dentinger PJ, Swenson CF
4
Stability of nifedipine in an extemporaneously compounded oral solution
Dentinger PJ, Swenson CF, Anaizi NH. ()
Am J Health-Syst Pharm - 2003 - ; 60: 1019-1022.
5
Stability of valganciclovir in an extemporaneously compounded oral liquid
Anaizi NH, Dentinger PJ, Swenson CF. ()
Am J Health-Syst Pharm - 2002 - ; 59: 1267-1270.
6
Stability of pantoprazole in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH. ()
Am J Health-Syst Pharm - 2002 - ; 59: 953-956.
7
Stability of amphotericin B in an extemporaneously compounded oral suspension.
Dentinger PJ, Swenson CF, Anaizi NH. ()
Am J Health-Syst Pharm - 2001 - ; 58: 1021-1024.
8
Stability of famotidine in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH. ()
Am J Health-Syst Pharm - 2000 - ; 57: 1340-1342.
9
Stability of mycophenolate mofetil in an extemporaneously compounded sugar-free oral liquid
Swenson CF, Dentinger PJ, Anaizi NH. ()
Am J Health-Syst Pharm - 1999 - ; 56: 2224-2226.
10
Stability of mycophenolate mofetil in an extemporaneously compounded oral liquid
Anaizi NH, Swenson CF, Dentinger PJ. ()
Am J Health-Syst Pharm - 1998 - ; 55: 926-929.
11
Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution
Anaizi NH, Swenson CF, Dentinger PJ. ()
Am J Health-Syst Pharm - 1997 - ; 54: 549-553.
12
Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid
Metras JI, Swenson CF, McDermott MP. ()
Am J Hosp Pharm - 1992 - ; 49: 1720-1724.
13
Instability of aqueous captopril solutions
Anaizi NH, Swenson C. ()
Am J Hosp Pharm - 1979 - ; 50: 486-488.

Förteckning över substanser   Molekyler Studerade   (12)  
Antimykotikum Oral lösning Amphotericin B
Diverse Oral lösning Benzoate sodium
Antihypertensivum Oral lösning Captopril
Analgetikum Oral lösning Codeine phosphate
Antiepileptikum Oral lösning Eslicarbazepine acetate
Antihistamin (H2) Oral lösning Famotidine
Immunsuppressivum Oral lösning Mycophenolate mofetil
Diverse ögondroppar N-acetylcysteine
Vasodilaterare Oral lösning Nifedipine
Protonpumpshämmare Oral lösning Pantoprazole sodium
Antiarrytmikum Oral lösning Procainamide hydrochloride
Antiviralt medel Oral lösning Valganciclovir
  Mentions Légales